Coherus Oncology, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
1.770
-0.070 (-3.80%)
At close: Apr 28, 2026, 4:00 PM EDT
1.786
+0.016 (0.91%)
After-hours: Apr 28, 2026, 5:14 PM EDT
Coherus Oncology Employees
Coherus Oncology had 147 employees as of December 31, 2025. The number of employees decreased by 81 or -35.53% compared to the previous year.
Employees
147
Change (1Y)
-81
Growth (1Y)
-35.53%
Revenue / Employee
$286,884
Profits / Employee
$1,143,020
Market Cap
272.97M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Cellectis | 229 |
| Zentalis Pharmaceuticals | 106 |
| C4 Therapeutics | 104 |
| Alector | 103 |
| Cybin | 50 |
| Protara Therapeutics | 46 |
| Eledon Pharmaceuticals | 33 |
| NovaBridge Biosciences | 30 |
CHRS News
- 7 weeks ago - Coherus Oncology Transcript: The Citizens Life Sciences Conference 2026 - Transcripts
- 7 weeks ago - Coherus Oncology Earnings Call Transcript: Q4 2025 - Transcripts
- 7 weeks ago - Coherus Oncology Reports Full Year and Fourth Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 7 weeks ago - Coherus Oncology Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Coherus Oncology to Report Full Year and Fourth Quarter 2025 Financial Results on March 9, 2026 - GlobeNewsWire
- 2 months ago - Coherus Oncology to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Coherus Oncology, Inc. Announces Closing of Public Offering of Common Stock - GlobeNewsWire
- 2 months ago - Coherus Oncology, Inc. Announces Pricing of Public Offering of Common Stock - GlobeNewsWire